Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EFIV | 75.38 | 0.46 | +0.61% |
| State Street SPDR S&P 500 ESG ETF (EFIV) | |||
| IVV | 781.97 | 4.70 | +0.60% |
| iShares Core S&P 500 ETF (IVV) | |||
| SPTE | 50.61 | 0.21 | +0.42% |
| SP Funds S&P Global Technology ETF (SPTE) | |||
| MMCA | 20.59 | 0.07 | +0.34% |
| NYLIM MacKay California Muni Intermediate ETF (MMCA) | |||
| GDOC | 35.95 | N/A | N/A |
| Future Health Care Equity ETF (GDOC) | |||
A.I.dvisor indicates that over the last year, UHS has been loosely correlated with HCA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % |
|---|---|---|
| UHS | 100% | +0.93% |
| UHS (2 stocks) | 82% Closely correlated | +1.15% |
| Hospital/Nursing Management (48 stocks) | 55% Loosely correlated | +0.73% |
a healthcare management company, which owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers
Industry HospitalNursingManagement
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +1.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHS advanced for three days, in 237 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 192 of 295 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UHS as a result. In 60 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for UHS turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 27 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
UHS broke above its upper Bollinger Band on September 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.392) is normal, around the industry mean (208.195). P/E Ratio (7.244) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.005) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.